1982
DOI: 10.1093/carcin/3.4.403
|View full text |Cite
|
Sign up to set email alerts
|

Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-O-tetradecanoylphorbol-13-acetate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
26
0

Year Published

1985
1985
2002
2002

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 70 publications
(32 citation statements)
references
References 0 publications
6
26
0
Order By: Relevance
“…This is further supported by the study of TPA-induced promotion in different species displaying varying hyperplasia after repeated TPA treatments, where there was generally a good correlation between the ability of TPA to promote tumours and its ability to produce a sustained epidermal hyperplasia (Sisskin & Barrett, 1981;Sisskin et al, 1982). The exception was the DBA/2 mouse strain which responded to TPA with a good sustained hyperplasia and a low tumour yield (Sisskin et al, 1982). However, this anomaly was recently shown to be due to inefficient initiation of this species by the dose of DMBA used by Sisskin and colleagues and if the correct dose of DMBA, or a different initiator such as MNNG was used, then DBA/2 mice responded to promotion by TPA with a high tumour yield (Di Giovanni et al, 1984) as predicted from their hyperplastic response (Sisskin et al, 1982).…”
Section: Two-stage Epidermal Tumourigenesismentioning
confidence: 84%
See 2 more Smart Citations
“…This is further supported by the study of TPA-induced promotion in different species displaying varying hyperplasia after repeated TPA treatments, where there was generally a good correlation between the ability of TPA to promote tumours and its ability to produce a sustained epidermal hyperplasia (Sisskin & Barrett, 1981;Sisskin et al, 1982). The exception was the DBA/2 mouse strain which responded to TPA with a good sustained hyperplasia and a low tumour yield (Sisskin et al, 1982). However, this anomaly was recently shown to be due to inefficient initiation of this species by the dose of DMBA used by Sisskin and colleagues and if the correct dose of DMBA, or a different initiator such as MNNG was used, then DBA/2 mice responded to promotion by TPA with a high tumour yield (Di Giovanni et al, 1984) as predicted from their hyperplastic response (Sisskin et al, 1982).…”
Section: Two-stage Epidermal Tumourigenesismentioning
confidence: 84%
“…This is further supported by the study of TPA-induced promotion in different species displaying varying hyperplasia after repeated TPA treatments, where there was generally a good correlation between the ability of TPA to promote tumours and its ability to produce a sustained epidermal hyperplasia (Sisskin & Barrett, 1981;Sisskin et al, 1982). The exception was the DBA/2 mouse strain which responded to TPA with a good sustained hyperplasia and a low tumour yield (Sisskin et al, 1982).…”
Section: Two-stage Epidermal Tumourigenesismentioning
confidence: 88%
See 1 more Smart Citation
“…By contrast, repeated applications of a promoter in uninitiated and initiated skin produces extensive hyperplasia (Setala et al, 1959). Different strains of mice with variable sensitivity to tumor promotion by TPA exhibit a good correlation of long term tumor production with sustained hyperplasia after 4 weeks of repeated TPA treatment (Sissken et al, 1982). There is also a correlation between thickness of epidermis and tumor production in the tumor-producing range of TPA concentrations (Raick et al, 1972).…”
Section: Precancerous Pulmonary Lesions Among Smokersmentioning
confidence: 99%
“…Usually a sustained chronic exposure to nongenotoxic chemicals at threshold levels and above must be maintained in order for the appearance of a disease state such as cancer to manifest itself (79). Exceptions to this generalization would be the acute exposure to a threshold level of a given nongenotoxic agent or to a mixture of nongenotoxicants at a critical period of embryonic or fetal development (92).…”
mentioning
confidence: 99%